 Image Provided by Pexels With a compound annual growth rate CAGR of 34.2, the global CAR-T cell therapy market is projected to hit 15.4 billion by 2028. This hypergrowth is largely driven by the incredible promise of CAR-T cell therapy as an effective, lasting way to fight cancer. 